This Week in European MedTech and HealthTech: 10th April 2026

Major HealthTech themes this week: fresh EU funding calls (Digital Europe, EIT Health), tightening AI-in-healthcare guardrails under the AI Act, and continued shift toward clinically validated, sovereign‑cloud digital infrastructure.

Policy and regulation

The Commission has updated guidance on how the AI Act dovetails with MDR/IVDR, raising expectations on data quality, risk management, and human oversight for high‑risk AI medical software.

The EU Health Technology Assessment (HTA) framework is now fully live, with joint clinical assessments ramping and effectively lifting the evidence bar for pan‑EU market access, particularly for digital and AI‑enabled devices.

Recent commentary stresses that the AI Act gives patients an explicit legal basis to demand understandable explanations of AI‑shaped medical decisions, which will force explainability and product‑design changes in clinical AI tools.

EU and pan-European funding levers

A new round of Digital Europe calls opens 21 April 2026, including topics on AI‑based image screening, digital solutions for regulatory compliance through data, and advanced skills for AI uptake in health, with a 1 October 2026 deadline.

EIT Health’s 2026 Innovation Validation Call offers up to €850k per project (50% co‑funding) for late‑stage digital health projects ready for clinical validation and launch; micro and small enterprises must take €400k–€500k of the grant at the commercialising entity.

The EIC has awarded €118m to 30 deep‑tech projects, with a sizeable share into healthy‑ageing biotech and modular multi‑robot surgical assistance platforms, reinforcing the robotics and longevity stack in Europe.

Market, product and infra moves

BD has launched its Pyxis Pro medication dispensing and Incada Connected Care platforms in Europe, hosted on AWS European Sovereign Cloud to square scale with EU data‑sovereignty and localisation requirements.

CMR Surgical’s Versius Plus robotic platform has now passed 40,000 procedures and is building out a richer digital analytics suite in Europe alongside a 2026 US commercial push, signalling continued convergence of robotics and data services.

Johnson & Johnson has released one‑year data for ICOTYDE, paired with new digital adherence monitoring tools tailored to European payers, highlighting the bundling of therapeutics with digital companions.

Capital flows and ecosystem signals

Q1 2026 global digital health funding reached about $7.1bn across 216 deals, with Europe second by region at roughly $1.16bn, driven notably by France (~$323m) and Switzerland (~$302m), underscoring a resilient European capital base despite modest YoY softness.

Analysts continue to characterise the current phase as a “Great Rationalization” in European HealthTech, with capital and corporate attention shifting from experimental AI to clinically validated, scalable solutions and robust cloud/data infrastructure.

Near-term conferences and platforms to watch

DMEA (Berlin, 21–23 April 2026) remains the flagship digital health fair in Europe with around 900 exhibitors, 20,500 visitors and hundreds of speakers, and will be a key venue for AI‑in‑EHR and hospital IT announcements.

The European Digital HealthTech Conference 2026 in Luxembourg is focusing on real-world adoption of digital medical devices and trusted solutions, drawing startups, corporates, and policymakers around implementation challenges.

To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email [email protected]

>>>> 

Key MedTech themes this week: MDR/IVDR “smarter certification” reform, the EUDAMED go‑live countdown, and UK moves to lock in long‑term CE reliance, all against a backdrop of EU funding and robotics/healthy‑ageing pushes.

Regulatory moves and compliance pressure

The Commission’s targeted MDR/IVDR simplification advances, including removal of the rigid five‑year certificate validity cap in favour of continuous, risk‑based surveillance to ease notified‑body bottlenecks.

Four key EUDAMED modules (actor, UDI/device, certificates, market surveillance) become mandatory on 28 May 2026; industry bodies are urging manufacturers to complete data validation now given litigation and transparency exposure.

The MHRA’s consultation (closing 10 April 2026) proposes indefinite recognition of CE‑marked devices in Great Britain under its International Reliance Framework, materially simplifying dual‑EU/UK strategies if adopted.

Strategic industry stance

MedTech Europe publicly backed the MDR/IVDR simplification package, framing it as a necessary correction to high compliance costs, unpredictable timelines, and risk‑classification issues that have constrained innovation and availability.

Legal and consultancy commentary this week emphasises that the reform aims to restore competitiveness and innovation while maintaining safety, suggesting a more pragmatic risk‑benefit balance for SMEs and niche device players.

Funding, innovation and robotics

The EIC just awarded €118m Pathfinder funding to 30 breakthrough projects, with a notable share going to biotechnology for healthy ageing and modular multi‑robot surgical assistance platforms, reinforcing the surgical robotics pipeline in Europe.

New Horizon Europe HORIZON‑HLTH‑2026 calls are open, with MedTech‑relevant topics including regulatory science for patient‑centred tech, NAMs to replace animal testing in device validation, and scaling cardiovascular innovation (including AI wearables).

EU4Health signed three new pre‑commercial procurement framework contracts (ceiling €225m over 98 months) to advance pandemic preparedness and vaccine innovation, signalling sustained device‑adjacent public investment in prevention and emergency tooling.

Market, product and infra signals

BD’s launch of Pyxis Pro medication dispensing and Incada Connected Care across Europe, built on cloud infrastructure, highlights hospital buyers’ focus on integrated medication management and connected‑care platforms.

CMR Surgical’s Versius Plus robotic system has now passed 40,000 procedures and is intensifying its digital analytics offering in Europe while preparing for a 2026 U.S. commercial push, underlining the data‑services layer around capital equipment.

Near‑term events and forums

MedTech Europe and leading firms are positioning April–June conferences (e.g., MedTech Summit Berlin in June) as key venues to unpack MDR/IVDR reform, EUDAMED implementation, and AI‑related compliance expectations.

To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email [email protected]